A Phase I Study of Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer
Phase of Trial: Phase I
Latest Information Update: 04 Jul 2014
At a glance
- Drugs Lapatinib (Primary) ; Trastuzumab
- Indications Breast cancer; Cancer metastases
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 03 Dec 2013 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 11 Sep 2012 Planned end date changed from 1 Jan 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.